EP1250146 - Bibliographic data
USE OF BOTULINUM TOXINS FOR TREATING DIABETES
| Last update | 29/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
ALLERGAN, INC. 2525 Dupont Drive
Irvine, CA 92612
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
DONOVAN, Stephen 27252 Calle Anejo
Capistrano Beach, CA 92624
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4
81925
MUNCHEN
Allemagne
|
| (21) Request number | EP01903262.2 |
|---|---|
| (22) Request date | 24/01/2001 |
| (11) Publication number | EP1250146 |
|---|---|
| Publication date | 02/01/2004 |
| (54) Title of the invention | USE OF BOTULINUM TOXINS FOR TREATING DIABETES |
|---|---|
| (51) International classification | None |
| International classification (before reform) | , |
| Claimed priority |
(31) Number: 491420 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 4 - Amount: 31 € - Due date 02/03/2004 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2004/1, of 31/03/2004 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 02/01/2004 Déchéance du brevet d'invention après période de grâce - Legal date 31/01/2004 |